Showing results (501-510 of 3,348) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|March 13, 2002
Cost-effectiveness analysis of exemestane compared with megestrol in advanced breast cancer: a model for Europe and AustraliaPeter Lindgren, Bengt Jönsson, Alberto Redaelli, et al.Pharmacoeconomics|April 13, 2002
Putting your money where your mouth is: willingness to pay for dental gelDebora Matthews, Angela Rocchi, Amiram GafniPharmacoeconomics|April 13, 2002
Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategiesPeter Wahlqvist, Ola Junghard, Andy Higgins, et al.Pharmacoeconomics|February 16, 2010
Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleedingAlan N Barkun, Viviane Adam, Joseph J Y Sung, et al.Pharmacoeconomics|November 10, 2005
Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapyPatricia Brown, Moran Ki, Betsy FoxmanPharmacoeconomics|December 18, 2009
Erlotinib: a pharmacoeconomic review of its use in advanced non-small cell lung cancerKatherine A Lyseng-WilliamsonPharmacoeconomics|December 13, 2005
Cost-effectiveness acceptability curves and a reluctance to loseJohan L Severens, Daniëlle E M Brunenberg, Elisabeth A L Fenwick, et al.Pharmacoeconomics|December 13, 2005
Estimating mean total costs in the presence of censoring: a comparative assessment of methodsTracey A YoungPharmacoeconomics|December 13, 2005
Pramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectivenessKatia Noyes, Andrew W Dick, Robert G Holloway, et al.Pharmacoeconomics|December 13, 2005
Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migrainePaul L McCormack, Rachel H FosterPageof 335